Beclobrate

CHEMBL152684 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

346.8 g/mol

LogP

5.8

Phase

4

A fibrate-class lipid-lowering agent that reduces triglycerides and raises HDL cholesterol by activating PPAR-alpha receptors in the liver to alter fat metabolism.

分子量

346.8000 g/mol

LogP

5.80

TPSA

35.50 Å²

リピンスキーの五則

適合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOC(=O)C(C)(CC)Oc1ccc(Cc2ccc(Cl)cc2)cc1

InChI

InChI=1S/C20H23ClO3/c1-4-20(3,19(22)23-5-2)24-18-12-8-16(9-13-18)14-15-6-10-17(21)11-7-15/h6-13H,4-5,14H2,1-3H3

Molecular Formula

C20H23ClO3

HBD / HBA

- / 3

回転可能結合数

8

重原子数

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A fibrate-class lipid-lowering agent that reduces triglycerides and raises HDL cholesterol by activating PPAR-alpha receptors in the liver to alter fat metabolism.

Yes, Beclobrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL152684. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 51348. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Beclobrate PillFYIで

構造

クイックデータ

分子式: C20H23ClO3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.